Insurance Denied His Cancer Scan Because He Had “No Symptoms”

“Your cancer might be back… but insurance says the scan isn’t medically necessary.”

A 53-year-old finishes chemotherapy for stage two colon cancer.

His oncologist orders a follow-up PET scan to determine whether the cancer is gone… or whether it has spread.

Insurance denies it.

Why?

Because he’s currently “asymptomatic.”

Read that again.

The patient doesn’t currently have symptoms… so the insurance company decided he doesn’t need the scan designed to catch the cancer BEFORE symptoms appear.

That’s literally the point of surveillance imaging.

To catch recurrence early.
To identify spread early.
To intervene BEFORE someone ends up stage four.

But somewhere inside a corporation, somebody with no relationship to this patient looked at an oncologist’s order and decided:
“Not medically necessary.”

This is what breaks people.

Not just the diagnosis.
Not just the chemo.
Not just the fear of cancer coming back.

It’s the exhaustion of realizing that after surviving cancer, you still have to fight a corporation to check whether the treatment even worked.

And let’s be honest about what this system incentivizes:

If the scan catches recurrence early, treatment is more effective.
If the scan is delayed until symptoms appear, the cancer may already be advanced.

That’s not “cost savings.”
That’s gambling with human lives.

An oncologist who treated this man for eight months ordered the scan.

But somehow, an insurance reviewer who never met him gets the final word.

Healthcare in America should not work like this.

Видео Insurance Denied His Cancer Scan Because He Had “No Symptoms” канала Aaron the Social Worker